THIRTEEN new Ozempic-like drugs are coming in the next few years as part of weight-loss goldrush


by dailym.ai

dailym.ai— Pharma will usher in four obesity drugs in 2027 alone in billion-dollar expansion. Global obesity drug market is projected to hit $100 billion by 2030, analysts say. READ MORE: Weight loss drug in trials burns fat

dailym.ai—Women are reporting 'Ozempic breasts' while taking weight-loss drugs. Plastic surgeons say the rapid weight loss can also cause the breasts to sag. Ozempic users have opened up about experiencing shifts in breast size. READ MORE: Can weight loss drugs cause facial aging? Experts views

Drudge Report—The Ozempic Effect: How a Weight Loss Wonder Drug Gobbled Up an Entire Economy. (Bloomberg) -- There is no escaping Ozempic and Wegovy. The diabetes and obesity drugs are a global phenomenon. They’ve won over the rich and famous, generated billions in sales and blown open a new market for weight loss drugs, which Goldman Sachs estimates will reach $100 billion a year by 2030.Most Read from BloombergTesla Axes Supercharger Team in Blow to Broader EV MarketNYPD Arrests Over 300 Protesters in Crackdown on College CampusesFed to Signal Delay of Interest-Rate CutsThe Ozempic...

Reading Eagle—Ozempic ‘oops’ babies spark debate about weight-loss shot use as fertility drugs. A surprising thing is happening to some women on weight-loss drugs who’ve struggled with fertility issues: They’re getting pregnant.